RecruitingNot ApplicableNCT04722263

Radiotherapy for Keloids

Primary Radiotherapy for the Treatment of Keloids: A Pilot Study

Sponsor

Montefiore Medical Center

Enrollment

15 participants

Start Date

Dec 1, 2020

Study Type

INTERVENTIONAL

Conditions

The purpose of this pilot study is to evaluate the safety and efficacy of radiation therapy (RT) in the treatment of unresected keloids.

Min Age: 18 Years

Clinically diagnosed keloid
Surgical excision of keloid is either contraindicated or patient has declined treatment with surgical excision (Note: patients with keloids that recurred after previous resection are eligible, as long as the current keloid is either unresectable or patient has declined resection)
Age ≥ 18
Study specific informed consent provided

Prior RT to the area of interest that would result in overlap of radiation therapy fields
Females of child bearing age without a negative serum pregnancy test prior to initiation of RT or unwilling to use contraception prior to and during the radiation course
Keloids in areas where radiation therapy introduces unacceptable high risk of toxicity as determined by the treating radiation oncologist
Uncontrolled intercurrent illness (e.g. symptomatic congestive heart failure, uncontrolled cardiac arrhythmia, or psychiatric situation) that would limit compliance with study requirements as judged by the treatment physicians

Interested in this trial?

Get notified about updates and connect with the research team.